通道阻断剂 拉西迪平因通过重编程托芬代谢促进抗瘤免疫力
Yuwen Sheng1, Chong Qiao1, Zhonghui Zhang2
1Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, China.
通道阻断剂拉西迪平抑制了二胺二氧化酶1 (IDO1),增强了乳腺癌的抗瘤免疫力. 这一发现通过调节瘤微环境,为代谢性免疫治疗开辟了新的途径.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 通道功能障碍与癌症的发展有关.
- 管抑制剂在瘤免疫调节中的作用尚不清楚.
- 印度醇胺2,3-二氧化酶1 (IDO1) 是 Tryptophan 代谢和免疫抑制中的一个关键酶.
研究的目的:
- 为了研究通道阻断剂拉西迪平对IDO1活性和表达的作用.
- 探索拉西迪平在瘤免疫调节中的作用及其在乳腺癌治疗中的潜力.
- 阐明拉西迪平的免疫调节作用背后的分子机制.
主要方法:
- 评估了IDO1.1的酶活性和表达.
- 评估了拉基迪平对效应T细胞和调控T细胞 (Tregs) 的影响.
- 研究了涉及通道 (CaV1.2/1.3) 的分子途径,Pyk2-JAK1-calmodulin复合体和NAD生物合成.
主要成果:
- 拉西迪平强烈抑制了IDO1的酶活性和表达.
- 拉西迪平激活了效应性T细胞和失能的Tregs,将"冷"瘤转化为"热"瘤.
- 拉西迪平向CaV1.2/1.3通道,以抑制IDO1转录,影响金氨酸通路和NAD水平.
结论:
- 拉西迪平通过抑制IDO1表现出免疫调节作用,为乳腺癌提供了一种新的治疗策略.
- 这项研究揭示了通道在IDO1-介导的酸盐代谢和瘤免疫力中的新作用.
- 拉西迪平对乳腺癌的代谢性免疫疗法具有前景,需要进一步的临床开发.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
相关概念视频
Tumor Immunotherapy
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
lncRNA - Long Non-coding RNAs
Antihypertensive Drugs: Action of Calcium Channel Blockers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
